Policy | September 02, 2021
Union Minister Mansukh Mandaviya chairs meet on eradicating TB
Coordinated and collaborative efforts will strongly contribute to the achievement of shared goals faster: Mandaviya
Coordinated and collaborative efforts will strongly contribute to the achievement of shared goals faster: Mandaviya
PPH is associated with almost 20 per cent of maternal mortality in India
Advance to Phase 3 follows positive interim Phase 1/2 immunogenicity and safety data. The global clinical trial will evaluate vaccine candidate GBP510 against the AZ/Oxford COVID-19 vaccine
The segment delivered strong sales growth of 20% YoY
A sum of Rs 70 crores and Rs 10 crores for a new Ayurvedic college in Assam and upgradation of the ayurvedic college in Guwahati respectively
The company will manufacture the products at its US FDA approved oral dosage facility at Goa in India
The clinical research organisation located in Hyderabad is a USFDA inspected facility
The manufacture of finished doses will commence in 2022 and at full operational capacity, the annual production is expected to exceed 100 million doses annually
Opaganib, a leading novel small molecule investigational oral pill in development for Covid-19, is a unique host targeted, dual antiviral and anti-inflammatory drug that acts on the cause and effect of the disease
Domestic business was up 41.9% YoY and 27.7% QoQ
Subscribe To Our Newsletter & Stay Updated
